Semaia Pharmaceuticals
Division of Hybrigenics SA
www.semaia.com
Latest From Semaia Pharmaceuticals
How the Fund-Raising Game Works in Europe
A handful of private European biotechs have raised money, but the process takes time, and the sums aren't great. Since VCs can invest in late-stage companies at the same prices they used to pay for newer ventures, early and mid-stage biotechs are being forced to broaden their search for funds, and meet growing demands for cost cutting and detailed spending plans. Both VCs and biotechs may emerge stronger from the squeeze, however.
Recent Dealmaking (06/2003)
Summarizing the month in European dealmaking.
Recent Dealmaking (10/2002)
Summarizing the month in European dealmaking.
Dealmaking (09/02)
Summarizing the month in European dealmaking.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Parent & Subsidiaries
- Hybrigenics SA
- Senior Management
- Contact Info
-
Semaia Pharmaceuticals
Phone: (49) 211 515 805 14
Emil Figge Strasse 76
Dortmund, D-44227
Germany
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Semaia Pharmaceuticals
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice